Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
The Journal of Biological Chemistry
|
January 25, 1974
Selective sulfenylation of tryptophan residues in alpha-lactalbumin of bovine milk
Y Shechter, A Patchornik, Y Burstein
Physiology & Behavior
|
June 1, 1989
Vanadate stimulates in vivo glucose uptake in brain and arrests food intake and body weight gain in rats
J Meyerovitch, Y Shechter, S Amir
Pediatric Research
|
February 1, 1978
Metabolic activity of developing rabbit lung
M Hamosh, Y Shechter, P Hamosh
Archives of Environmental Health
|
January 1, 1979
Effect of tobacco smoke on the metabolism of rat lung
M Hamosh, Y Shechter, P Hamosh
FEBS Letters
|
October 1, 1973
Activation of chicken pepsin by modification of its cysteine residue with o-nitrophenyl sulfenyl chloride
R Becker, Y Shechter, Z Bohak
Journal of Biochemical and Biophysical Methods
|
March 1, 1992
Preparation and application of radioiodinated sulfhydryl reagents for the covalent labeling of SH-proteins present in minute quantities
E Hazum, A Shisheva, Y Shechter
Diabetes
|
August 1, 1992
Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats
A Shisheva, D Gefel, Y Shechter
The Journal of Biological Chemistry
|
April 1, 1994
Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity
G Elberg, J Li, Y Shechter
Diabetes
|
July 2, 1999
New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin
E Gershonov, Y Shechter, M Fridkin
Endocrinology
|
January 1, 1994
The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats
A Shisheva, O Ikonomov, Y Shechter
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
The Journal of Biological Chemistry
|
January 25, 1974
Selective sulfenylation of tryptophan residues in alpha-lactalbumin of bovine milk
Y Shechter, A Patchornik, Y Burstein
Physiology & Behavior
|
June 1, 1989
Vanadate stimulates in vivo glucose uptake in brain and arrests food intake and body weight gain in rats
J Meyerovitch, Y Shechter, S Amir
Pediatric Research
|
February 1, 1978
Metabolic activity of developing rabbit lung
M Hamosh, Y Shechter, P Hamosh
Archives of Environmental Health
|
January 1, 1979
Effect of tobacco smoke on the metabolism of rat lung
M Hamosh, Y Shechter, P Hamosh
FEBS Letters
|
October 1, 1973
Activation of chicken pepsin by modification of its cysteine residue with o-nitrophenyl sulfenyl chloride
R Becker, Y Shechter, Z Bohak
Journal of Biochemical and Biophysical Methods
|
March 1, 1992
Preparation and application of radioiodinated sulfhydryl reagents for the covalent labeling of SH-proteins present in minute quantities
E Hazum, A Shisheva, Y Shechter
Diabetes
|
August 1, 1992
Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats
A Shisheva, D Gefel, Y Shechter
The Journal of Biological Chemistry
|
April 1, 1994
Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity
G Elberg, J Li, Y Shechter
Diabetes
|
July 2, 1999
New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin
E Gershonov, Y Shechter, M Fridkin
Endocrinology
|
January 1, 1994
The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats
A Shisheva, O Ikonomov, Y Shechter
Page
of 14